 |
|
|
| |
norUrsodeoxycholic acid (norUDCA) improves
non-alcoholic fatty liver disease (NAFLD):
Results from a randomized placebo-controlled,
double-blind phase IIa study
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
S. Traussnigg, J. M. Schattenberg, M. Demir, J. Wiegand, A. Geier, G. Teuber, W. P. Hofmann, A. E. Kremer, F. Spreda, J. Kluwe, J. Petersen, T. Boettler, E. Halilbasic, R. Greinwald, M. Proels, M. P. Manns, P. Fickert, M. Trauner
|
| |
|
|
|
|
|
